D-二聚体阳性患者在临床科室的分布及其检测临床意义  

The distribution and clinical significance of D-dimer positive patients

作　　者：王佳颖[1,2] 胡晓渤[3] 刘湘[1] 张吉才[2] 宁勇[1] 

机构地区：[1]湖北中医药大学检验学院,湖北武汉430065 [2]湖北医药学院附属太和医院检验部,湖北十堰442000 [3]湖北医药学院附属太和医院信息资源部,湖北十堰442000

出　　处：《国际检验医学杂志》2015年第10期1421-1422,共2页International Journal of Laboratory Medicine

摘　　要：目的探讨D-二聚体阳性患者在临床各科室的分布及其临床意义。方法选取该院收治的1 003例患者,采用胶乳增强免疫比浊法对其血浆D-二聚体水平进行检测。结果 ICU科、心内科、呼吸内科、骨科、普外科、肝病科、神经外科、妇产科和肿瘤科患者总阳性率为44.1%。同时,弥散性血管内凝血(DIC)、深静脉血栓、肺动脉栓塞、心脑血管疾病、肝脏疾病和恶性肿瘤患者中的D-二聚体阳性者分别为86、34、26、24、18、12例。结论血浆D-二聚体水平的检测可用于血栓性疾病的预防、监控。Objective To investigate the distribution and clinical significance of D‐Dimer positive patients .Methods 1 003 D‐di‐mer positive patients were enrolled in the study ,which were measured by latex enhanced immune turbidimetry .Results The total positive rate of ICU ,cardiology ,respiratory medicine ,orthopedics ,general surgery ,liver disease ,neurosurgery ,obstetrics and gyne‐cology ,oncology departments was 44 .1% .The numbers of D‐dimer positive patients with diffuse intravascular coagulation ,deep vein thrombosis ,pulmonary embolism ,heart cerebrovascular disease ,liver disease ,malignant tumor were 86 ,34 ,26 ,24 ,18 and 12 , respectively .Conclusion The determination of plasma D‐dimer could be used in thrombotic disease prevention and monitoring .

关 键 词：D-二聚体 继发性纤溶亢进 临床分布 

分 类 号：R446.6[医药卫生—诊断学]